Vaccine Component Articles & Analysis
10 news found
About PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] VBI’s hepatitis B vaccine is the only 3-antigen hepatitis B vaccine, comprised of the three hepatitis B surface antigens of the hepatitis B virus – S, pre-S1, and pre-S2. ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select European markets for the marketing and distribution of PreHevbri® [Hepatitis B vaccine (recombinant, adsorbed)], the only 3-antigen hepatitis B vaccine approved in Europe. ...
Dillman will be responsible for leading VBI’s commercial strategy, sales, and sales operations, including the commercialization of VBI’s 3-Antigen Hepatitis B Vaccine (HBV), PreHevbrio™ [Hepatitis B Vaccine (Recombinant)]. ...
“In the PROTECT study, more adults were protected with VBI’s 3-antigen vaccine than with the single-antigen vaccine, and in this follow-up analysis we continued to see the benefit of the 3-antigen vaccine,” said Francisco Diaz-Mitoma, M.D., Ph.D., VBI’s Chief Medical Officer. ...
(NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced preclinical data, in collaboration with Gilead Sciences, Inc., on arenaviral therapeutic vaccines that are being studied as a component of a potential functional curative regimen for human immunodeficiency virus ...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that an abstract highlighting long-term durability of immune response data following vaccination with VBI’s 3-antigen hepatitis B (HBV) vaccine has been accepted for oral ...
Abera Bioscience AB is a biotechnology company that develops vaccine candidates based on patented vaccine platforms. The latest vaccine platform makes it possible to produce single, or multiple, antigens in so-called protein bodies. Antigens are the pathogen-specific components of vaccines that elicit immune ...
Now the company has developed another platform that makes it possible to efficiently produce single or multiple antigens into so-called protein bodies that can be given as a vaccine. Antigens are the components of vaccines that are supposed to elicit immune responses to protect against infectious pathogens or to combat diseases like cancer. ...
After a fourth dose, administered one year later, antibody levels were boosted to levels similar to the peak titers achieved following the primary series of vaccinations. The Matrix-M component of the malaria vaccine will be manufactured and supplied to SII by Novavax. Under Novavax' agreement with Serum Institute, SII has rights to use Matrix-M ...
ByNovavax
For example, the ACQUITY UPLC H-Class Bio System is ideally paired with Waters’ new bioseparations technology columns: the ACQUITY UPLC BEH200 SEC column, the first UPLC analytical size-exclusion chromatography (SEC) solution for the characterization of proteins and their aggregates, and the Protein-PakHi Res IEX column, designed for the analysis of biomolecules including monoclonal ...